Prevalence of overweight, obesity, and severe obesity among children and adolescents aged 219 years: united States, 19631965 through 20172018
Novo Nordisks handling of the Ozempic litigation showcases a company struggling to shield its lucrative drug from scrutiny, despite clear evidence linking their product to serious health complications
At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems
Garg A, Grundy SM
Ultra-Processed Foods Under Fire A strong recommendation to avoid highly processed, sugary, packaged, and ready-to-eat foods, including sodas, fruit drinks, and energy drinks